While the likelihood of cannabis legalization or descheduling on the federal level in 2022 remains relatively low, policy analysts and advocates are beginning to debate the impact federal legalization might have on existing state industries. In particular, they are starting to discuss the transition to interstate commerce, should cannabis become legalized at the federal level. Discussions are also forming around how and when such large-scale change should be implemented to minimize negative impacts on public health and safety and adequately address the interests of patients, users, and small businesses.
Join the Drug Enforcement and Policy Center for a discussion of these and other topics with a panel of experts.
Scott Bloomberg, Associate Professor of Law, University of Maine School of Law
Geoffrey Lawrence, Director of Drug Policy, Reason Foundation
Adam J. Smith, Founder and Executive Director, Alliance for Sensible Markets
Shaleen Title, Distinguished Cannabis Policy Fellow, Drug Enforcement and Policy Center, The Ohio State University
Jeremy Berke, Senior Reporter, Business Insider